Find a Clinical Trial
The clinical trials at Gundersen offer the same cutting-edge treatments as those at other top medical research hospitals – and often much sooner than they’re available to everyone.
Showing 10 of 89 trials
13-004051
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
Adult (18-64)
Older adult (65+)
S1900E
Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
Adult (18-64)
Older adult (65+)
20180008
The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
Adult (18-64)
Older adult (65+)
NRG-CC009
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
Adult (18-64)
Older adult (65+)
NRG-BN011
Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine®) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma
Adult (18-64)
Older adult (65+)
EA2197
Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer
Adult (18-64)
Older adult (65+)
A211901
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Adult (18-64)
Older adult (65+)
A021806
Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer
Adult (18-64)
Older adult (65+)
NCI-2017-00009
Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
Adult (18-64)
Older adult (65+)
NCI-2022-01540
Testing the Addition of Trastuzumab or Trastuzumab/Pertuzumab to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Adult (18-64)
Older adult (65+)